Provectus Biopharmaceuticals, Inc. (PVCT)
OTCMKTS · Delayed Price · Currency is USD
0.0600
-0.0020 (-3.23%)
Jul 27, 2026, 3:22 PM EST
PVCT Market Cap
PVCT has a market cap or net worth of $25.22 million as of July 28, 2026. Its market cap has decreased by -20.00% in one year.
Market Cap
25.22M
Enterprise Value
27.77M
Revenue
57.48K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.06
ChartMarket Cap Chart
Since April 24, 2002, PVCT's market cap has increased from 4.32K to 25.22M, an increase of 583,351.94%. That is a compound annual growth rate of 42.94%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 27, 2026 | 25.22M | 7.33% |
| Dec 31, 2025 | 23.49M | -53.46% |
| Dec 31, 2024 | 50.48M | 25.33% |
| Dec 29, 2023 | 40.27M | -11.35% |
| Dec 30, 2022 | 45.43M | 96.93% |
| Dec 31, 2021 | 23.07M | -1.55% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cell Source | 44.16M |
| Arch Biopartners | 41.09M |
| ProText Mobility | 36.92M |
| Sangamo Therapeutics | 26.93M |
| EOM Pharmaceuticals Holdings | 26.41M |
| BetterLife Pharma | 23.88M |
| ZIVO Bioscience | 20.76M |
| Galera Therapeutics | 18.20M |